Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Owens & Minor $600 million notes offering
The high-yield notes are due 2030
Home Depot $4 billion notes offering
The investment-grade notes are due 2025, 2027, 2032 and 2052
ING Groep $4 billion senior debt securities
The investment-grade notes are due 2026, 2028 and 2033
AN2 Therapeutics $69 million IPO
The shares are listed on the Nasdaq Global Select Market
Banco Santander $2.75 billion senior preferred and non-preferred notes offering
We advised Banco Santander on its offering of fixed-rate and fixed-to-fixed-rate notes
British American Tobacco $200 million notes offering
The investment-grade notes are due 2032
JPMorgan Chase €2.5 billion notes offering
We advised JPMorgan Chase on the euro notes offering
Toyota Motor Credit $3 billion notes offering
We advised TMCC on the SEC-registered offering
Grupo Aeroméxico emerges from chapter 11
We advised Grupo Aeroméxico as debtor in possession
NatWest Markets $1.5 billion notes offering
We advised NatWest Markets on its Rule 144A medium-term notes program update and notes offering